Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

A newly developed DNAm-IgE score using 107 CpGs may identify early epigenetic patterns linked to childhood respiratory morbidity.

Investigators from VHIO, which is part of the Vall Hebron Campus, publish the first study to address the impact of the exposome on early-onset colorectal cancer through epigenetic signatures. The ...

April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...